The North America scar treatment market is a multi-billion dollar industry. Scar treatment products aim to improve the appearance and texture of scars resulting from injuries, acne, burns or surgery. They include topical gels, creams, patches, laser therapy devices, injectable treatments and silicone sheets and gel sheeting.
The global North America scar treatment market is estimated to be valued at US$ 4,348.7 million in 2023 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Minimally invasive procedures such as laser therapy, injectable treatments and microneedling reduce treatment downtime and risk of infection compared to conventional surgical procedures. They are gaining popularity due to their effectiveness and convenience. According to the American Society of Plastic Surgeons, non-surgical cosmetic procedures grew by about 10% between 2017 and 2018 in the US. The trend towards minimally invasive procedures is expected to continue stimulating demand for scar treatment products over the forecast period.
The above mentioned heading points to increasing adoption of minimally invasive procedures as a key opportunity for the North America scar treatment market growth. Minimally invasive procedures offer several advantages over conventional surgical procedures such as lower risks, less pain, shorter recovery times and improved cosmetic outcomes. For example, laser therapy uses focused light energy to break scar tissue bonds and stimulate collagen production. It effectively treats hypertrophic and keloid scars with minimal damage to surrounding skin. Similarly, injectable treatments involving corticosteroids or 5-fluorouracil reduce scar appearance by inhibiting scar tissue formation and boosting collagen degradation. They provide scarring solutions via office-based procedures. The convenience and effectiveness of these procedures is driving their increased usage among medical practitioners and patients alike. Various studies also show high patient satisfaction levels with minimally invasive scar treatments. As physicians and consumers recognize their benefits over invasive treatments, demand for associated scar treatment products is projected to rise substantially.
The North America scar treatment market is dominated by the surgicalscar segment. Surgical scars make up nearly half the total scar treatmentsmarket as they are frequently large and visible and tend to heal moreprominently. Surgical scars are often the result of more invasiveprocedures like C-sections, organ transplants, and cancer surgeries.Patients seek treatment to minimize the appearance of these scars andreduce psychological impacts.
Political: Healthcare reforms in countries like the US could impactmarket dynamics by changing healthcare coverage and reimbursementmodels.
Economic: The market is dependent on discretionary consumer spendingon aesthetic procedures. Economic downturns may slow market growth.
Social: Increasing awareness about scar treatment options and focus onbody image has boosted social acceptance of such treatments.
Technological: Advances in laser, injection, and surgical scar revisiontechnologies have improved outcomes and driven new productinnovation.
The Global North America Scar Treatment Market Size is expected to witness highgrowth over the forecast period supported by strong economicconditions and consumer spending power in the region. The UnitedStates currently dominates the regional market and is expected tocontinue its lead driven by widespread availability and adoption ofadvanced scar treatment technologies.
Within North America, the United States accounts for the major shareof the scar treatment market due to large healthcare spending. Thepresence of major market players along with high awareness andadoption of scar treatment products and procedures in the US drivesits large market share. Canada is projected to register the fastestgrowth owing to growing medical tourism and increasing focus onestheticcosmetic procedures.
Key players operating in the North America scar treatment market areScarAway, Thrive Aesthetics MN, HRA Pharma, MARLO WHITNEY, Smith &Nephew Inc, Merz Therapeutics, Enaltus LLC, Oculus InnovativeSciences, Inc, CCA Industries, Bausch Health Companies Inc., CandelaMedical, Perrigo Company plc.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it